Drug Information

Drug General Information
Drug ID
D04MMJ
Former ID
DPR000010
Drug Name
ADX-2 series
Drug Type
Small molecular drug
Indication Schizophrenia [ICD9: 295; ICD10:F20] Preclinical [536463]
Company
Addex
Structure
Download
2D MOL

3D MOL
Formula
C20H27BrN2O
Canonical SMILES
CCC1CC2CC3C1N(C2)CCC4=C3NC5=C4C=C(C=C5)OC.Br
InChI
1S/C20H26N2O.BrH/c1-3-13-8-12-9-17-19-15(6-7-22(11-12)20(13)17)16-10-14(23-2)4-5-18(16)21-19;/h4-5,10,12-13,17,20-21H,3,6-9,11H2,1-2H3;1H
InChIKey
NVBHPBGGYJRLTF-UHFFFAOYSA-N
PubChem Compound ID
9821813
PubChem Substance ID
14780759, 24125166, 44857772, 80618566, 134339494
Target and Pathway
Target(s) NMDA receptor Target Info Antagonist [536463]
References
Ref 536463The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31.
Ref 536463The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. Epub 2007 Jul 31.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.